![](/img/cover-not-exists.png)
Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome
Przepiera-BÄdzak, Hanna, Fischer, Katarzyna, Brzosko, MarekYear:
2018
Journal:
Archives of Medical Science
DOI:
10.5114/aoms.2018.76953
File:
PDF, 79 KB
2018